Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group Co. The company is expanding its overseas market share via acquisitions. Photo: Handout
Fosun Pharmaceutical wants to be the Xiaomi of China’s drug industry
With a focus on overseas emerging markets, Fosun Pharma wants to challenge western rivals the same way Xiaomi did with Apple in smartphones
Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group Co. The company is expanding its overseas market share via acquisitions. Photo: Handout
